- Home
- AM vs MRNA Comparison
AM vs MRNA Comparison
Compare AM & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AM | MRNA |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.5B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AM | MRNA |
|---|---|---|
| Price | $21.72 | $50.79 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 12 |
| Target Price | $19.50 | ★ $33.00 |
| AVG Volume (30 Days) | 3.2M | ★ 10.4M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.16% | N/A |
| EPS Growth | 3.61 | ★ 21.77 |
| EPS | ★ 0.86 | N/A |
| Revenue | $1,188,426,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | $3.65 | $6.38 |
| Revenue Next Year | $5.13 | $12.33 |
| P/E Ratio | $25.15 | ★ N/A |
| Revenue Growth | ★ 7.43 | 4.29 |
| 52 Week Low | $15.08 | $22.28 |
| 52 Week High | $21.66 | $55.20 |
Technical Indicators
Market Signals| Indicator | AM | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 79.44 | 69.58 |
| Support Level | $17.20 | $23.73 |
| Resistance Level | N/A | $55.20 |
| Average True Range (ATR) | 0.52 | 3.03 |
| MACD | 0.17 | 0.52 |
| Stochastic Oscillator | 90.48 | 80.13 |
Price Performance
Historical ComparisonAbout AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.